Journal of Clinical Rheumatology and Immunology (Dec 2021)

Uveitis and Rheumatological Diseases

  • Chloe Kwong Yee Cheung,
  • Mandy Oi Man Wong,
  • Carmen Kar Mun Chan,
  • Ho Yin Chung

DOI
https://doi.org/10.1142/S2661341721300068
Journal volume & issue
Vol. 21, no. 2
pp. 70 – 77

Abstract

Read online

Uveitis is the most common ophthalmological disorder in the field of rheumatology, accounting for a significant proportion of visual morbidity, both locally and internationally. Causative factors can be divided into infectious and noninfectious etiologies. The diagnosis of uveitis is a major challenge due to heterogeneity in presentation. The disease course may be acute monophasic, recurrent, or chronic relapsing. Complications include posterior synechiae, secondary cataract, ocular hypertension or glaucoma, macular edema, retinal vascular occlusion, epiretinal membrane, and so on, and ultimately visual loss. Antimicrobial therapy is indicated for infection, whereas noninfectious uveitis warrants a combination of steroids, immunosuppressives, and anti-inflammatory agents. With the advancement of biologics, treatment strategies in chronic, noninfectious uveitis have had multiple breakthroughs, particularly in treatment-resistant cases. This article provides a review of the diagnostic approach to uveitis based on symptomatology and ophthalmological findings, and discussion of relevant treatment modalities and strategies.

Keywords